The present invention relates to a method for preparing a peptide of following general formula (I). It also relates to specific peptides, which have been prepared by the method according to the invention, and key synthesis intermediates.
C07K 7/06 - Linear peptides containing only normal peptide links having 5 to 11 amino acids
C07K 7/56 - Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
The invention provides for novel peptide derivatives and compositions comprising the same. The invention further provides methods of treatment comprising administering novel peptide derivatives and/or compositions comprising the same.
C07C 269/04 - Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
C07C 227/04 - Formation of amino groups in compounds containing carboxyl groups
C07C 227/16 - Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
C07C 227/18 - Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
C07D 263/06 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
5.
PEPTIDE DERIVATIVES AS ANTIBIOTICS AND USES THEREOF
The invention provides for novel peptide derivatives and compositions comprising the same. The invention further provides methods of treatment comprising administering novel peptide derivatives and/or compositions comprising the same. Disclosed is a compound A of formula (I): Ra-Xaai -Xaa2-Xaa3- Xaa4-Xaa5-Xaa6-Xaa7-Xaa8-Xaa9- Rb (I), for treating or preventing a bacterial infection in a subject.
The invention provides for novel peptide derivatives and compositions comprising the same. The invention further provides methods of treatment comprising administering novel peptide derivatives and/or compositions comprising the same.
C07C 269/04 - Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
C07C 227/04 - Formation of amino groups in compounds containing carboxyl groups
C07D 263/06 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (France)
Inventor
Gualtieri, Maxime
Villain-Guillot, Philippe
Givaudan, Alain
Pages, Sylvie
Abstract
The present invention relates to antibiotic compounds, methods for producing said compounds, pharmaceutical compositions comprising said compounds, and methods of treatment comprising administering said compounds and/or compositions comprising said compounds.
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (France)
Inventor
Gualtieri, Maxime
Villain-Guillot, Philippe
Givaudan, Alain
Pages, Sylvie
Abstract
Antibiotic compounds purified from Xenorhabdus cabanillasii strain CNCM I-4418 and methods for producing said compounds and pharmaceutical compositions comprising said compounds and a pharmaceutically acceptable carrier for use in the treatment of fungal disease. Xenorhabdus cabanillasii strain CNCM I-4418.
C07K 7/56 - Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
The invention relates to a method for identifying a secondary metabolite with antibiotic properties produced by a producing micro-organism, including culturing the producing micro-organism in the presence of an inductor micro-organism and detecting the production of at least one secondary metabolite with antibiotic properties.
C12N 1/00 - Microorganisms, e.g. protozoaCompositions thereofProcesses of propagating, maintaining or preserving microorganisms or compositions thereofProcesses of preparing or isolating a composition containing a microorganismCulture media therefor